Nordea Investment Management’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-47,972
Closed -$3.87M 992
2019
Q2
$3.87M Sell
47,972
-2,619
-5% -$184K 0.01% 605
2019
Q1
$3.38M Buy
50,591
+100
+0.2% +$7.57K 0.01% 765
2018
Q4
$3.76M Buy
50,491
+2,623
+5% +$217K 0.01% 647
2018
Q3
$4.41M Buy
47,868
+17,605
+58% +$1.68M 0.01% 665
2018
Q2
$2.98M Buy
+30,263
New +$3.38M 0.01% 666

Other funds holding CMD

Nordea Investment Management's CMD Position: Q3 2019 in Review

Nordea Investment Management sold out of Cantel Medical Corporation (CMD) in Q3 2019, closing a stake of 47,972 shares — an estimated $3.87M sold.

Nordea Investment Management first reported a position in CMD in Q2 2018 and held it in 5 quarters. The position peaked at $4.41M in Q3 2018. 244 funds tracked by Wall St. Rank hold CMD as of Q3 2019.

  • Nordea Investment Management reported no remaining Cantel Medical Corporation position as of Q3 2019 after selling out during the quarter.
  • Nordea Investment Management sold 47,972 Cantel Medical Corporation shares in Q3 2019, an estimated $3.87M.
  • Nordea Investment Management first reported a position in Cantel Medical Corporation in Q2 2018 and held it in 5 quarters.
  • Nordea Investment Management's Cantel Medical Corporation position peaked at $4.41M in Q3 2018.
  • 244 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2019.

Based on Nordea Investment Management's 13F filing for Q3 2019, filed 13 Nov 2019.